The Belgian university will use the WaferGen system in validating a biomarker signature for neuroblastoma in children, as well as other applications.
Researchers from Australia and the US have used genotyping, microRNA analysis, and mitochondrial and transcriptome sequencing to tackle a transmissible Tasmanian devil cancer.
American and Serbian researchers have identified telltale miRNA changes in the saliva of individuals with oral cancer — a finding that they say may eventually yield saliva-based oral cancer diagnostic tests.
Rosetta Genomics, Alnylam Pharmaceuticals, Massachusetts Institute of Technology
The firm published data from a study showing that the same biomarker used in its miRNA-based test for squamous lung cancer provided 96 percent sensitivity.
Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.
The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.
US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.
In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.